Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market.
Early evaluation of potential drug-drug interactions
Addressing the potential for adverse interactions among coadministered drugs before marketing a new drug can save time, money, and lives. In this reference, distinguished international experts comprehensively review the issues, relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. Focusing on evaluation during the drug discovery process, Drug-Drug Interactions in Pharmaceutical Development:
*
Details the major scientific concepts and preclinical experimental approaches
*
Covers both clinical and nonclinical aspects
*
Discusses in vitro and in vivo methodologies
*
Covers genomic approaches
*
Addresses U.S., European, and Japanese regulations
*
Includes a chapter on herbal drug interactions
Compiling current information into one accessible resource, this is an excellent reference for industrial scientists and regulatory specialists in drug development as well as academic researchers and students in the fields of pharmacology, drug metabolism, and toxicology.
